HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Zhi-Ping Ma Selected Research

ELAV-Like Protein 2

2/2020TCL1 as a hub protein associated with the PI3K/AKT signaling pathway in diffuse large B-cell lymphoma based on proteomics methods.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Zhi-Ping Ma Research Topics

Disease

3Diffuse Large B-Cell Lymphoma (Lymphoma, Large Cell, Diffuse)
11/2021 - 09/2019
2Neoplasms (Cancer)
09/2019 - 01/2017
1Glioma (Gliomas)
01/2023
1Hodgkin Disease (Hodgkin's Disease)
03/2022
1Hyperplasia
11/2021
1Lymphoma (Lymphomas)
09/2019

Drug/Important Bio-Agent (IBA)

3Proteins (Proteins, Gene)FDA Link
01/2023 - 09/2019
1Isocitrate Dehydrogenase (Isocitrate Dehydrogenase (NAD+))IBA
01/2023
1Biomarkers (Surrogate Marker)IBA
01/2023
1RNA (Ribonucleic Acid)IBA
03/2022
1MicroRNAs (MicroRNA)IBA
11/2021
1Proto-Oncogene Proteins c-akt (Protein Kinase B)IBA
02/2020
1ELAV-Like Protein 2IBA
02/2020
1Cetuximab (Erbitux)FDA Link
01/2017

Therapy/Procedure

1Aftercare (After-Treatment)
09/2019
1Therapeutics
09/2019